Search

Displaying results 5901 - 5910 of 6183 in total
  1. Drug

    Naluzotan

    go.drugbank.com/drugs/DB05562
    Investigational

    Categories: Serotonin Receptor Agonists, Serotonin 5-HT1 Receptor Agonists
  2. Drug

    TC-2696

    go.drugbank.com/drugs/DB05576
    Experimental

  3. Drug

    LY-517717

    go.drugbank.com/drugs/DB05713
    Investigational

    LY517717 is an investigational oral direct inhibitor of activated Factor Xa. It is believed to be Lilly's PMD-3112 (licensed from Amgen).

  4. Drug

    CRx-401

    go.drugbank.com/drugs/DB05775
    Experimental

    CRx-401 is a novel insulin sensitizer designed to provide anti-diabetic activity without promoting weight gain. It consists of a low dose of the analgesic diflunisal in conjunction with a modified-release therapeutic dose of bezafibrate,...

  5. Drug

    AL-02

    go.drugbank.com/drugs/DB06065
    Experimental

  6. Drug

    TG1024

    go.drugbank.com/drugs/DB06180
    Experimental

  7. Drug

    Ocaperidone

    go.drugbank.com/drugs/DB06229
    Experimental

  8. Drug

    Relacatib

    go.drugbank.com/drugs/DB06367
    Investigational

  9. Drug

    Dotarizine

    go.drugbank.com/drugs/DB06446
    Experimental

    Categories: Serotonin Receptor Antagonists
  10. Drug

    Mitumomab

    go.drugbank.com/drugs/DB06462
    Experimental

    Mitumomab, an anti-BEC-2 monoclonal antibody derived from mice, was previously studied to treat small cell lung carcinoma in combination with BCG vaccination.